Autres langues Theralase Technologies Inc.

Actions

TLT

CA88337V1004

Equipement et technologie médicale avancés

Marché Fermé - Toronto S.E. 21:59:54 01/10/2026			Varia. 5j.	Varia. 1 janv.
0,1800 ^CAD	0,00%		+2,86%	+9,09%

15/09	Theralase Technologies lance l'analyse toxicologique BPL du Rutherrin	CI
29/08	Transcript : Theralase Technologies Inc., Q1 2026 Earnings Call, Jun 09, 2026

Autres langues

18/09	Correcting and Replacing: Theralase(R) Releases Q2 2026 Financial Statements
15/09	Theralase Technologies Commences GLP Toxicology Analysis of Rutherrin
15/09	Theralase(R) Commences GLP Toxicology Analysis of Rutherrin(R)
28/08	Theralase Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
28/08	Theralase(R) Releases Q2 2026 Financial Statements
24/08	Theralase Technologies Closes C$3.6 Million Private Placement
24/08	Theralase(R) Closes C$3.6 Million Brokered Financing
24/08	Theralase Technologies Inc. announced that it has received CAD 3.555 million in funding
10/08	Theralase(R) Announces $5 Million Brokered LIFE Offering
10/08	Theralase(R) Technologies Grants Stock Options
10/08	Theralase Technologies Inc. announced that it expects to receive CAD 5 million in funding
07/08	Theralase(R) Grants Stock Options
04/08	Theralase(R) Engages Global One Media to Expand Global Investor Awareness
30/06	Theralase(R) Receives Receipt for C$100 Million Base Shelf Prospectus
16/06	Theralase Technologies : ® Releases Q1 2026 Financial Statements
03/06	Theralase(R) Lists Warrants on the TSXV
29/05	Theralase Technologies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
29/05	Theralase(R) Releases Q1 2026 Financial Statements
22/05	Theralase Technologies : ® Closes C$4.8 Million Offering
20/05	Theralase Technologies Raises $4.8 Million Via Brokered Private Placement Offering
20/05	Theralase(R) Closes C$4.8 Million Offering
20/05	Theralase Technologies Inc. announced that it has received CAD 4.16167 million in funding
06/05	Theralase(R) Announces $4 Million Brokered LIFE Offering
05/05	Theralase Technologies Inc. announced that it expects to receive CAD 4 million in funding
04/05	Theralase Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2025